Proactive news headlines including Elon Musk, Vuzix, Context Therapeutics and American Manganese - StreetInsider.com

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

New York , Dec. 03, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

  • Vuzix signs distribution agreement with Austrian firm, receives initial Smart Glasses order click here
  • Elon Musk sells US$1bn worth of Tesla shares after exercising further options click here
  • Revive Therapeutics expands research with Bucillamine as potential treatment for Omicron variant click here
  • Great Atlantic Resources intersects high-grade quartz veins and visible gold at its Golden Promise project in Newfoundland click here
  • Harbor Custom Development acquires 438-acre master planned community near Vancouver, B.C. for $14M click here
  • LexaGene closes multiple MiQLab sales as it makes good progress in sales cycle click here
  • KetamineOne subsidiary KGK Science helps its client Hofseth Biocare receive New Dietary Ingredient status from US FDA click here
  • American Manganese poised to strengthen its global patent portfolio with latest filing click here
  • Context Therapeutics reports 3Q results during a “pivotal” period for the company click here

About Proactive

  • Proactive is a unique tech-enabled platform providing companies globally with a comprehensive investor engagement solution across their business lifecycle.
  • With six offices on three continents,...


Read Full Story: https://www.streetinsider.com/Globe+Newswire/Proactive+news+headlines+including+Elon+Musk%2C+Vuzix%2C+Context+Therapeutics+and+American+Manganese/19307820.html

Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.